array:23 [
  "pii" => "S1578219019302070"
  "issn" => "15782190"
  "doi" => "10.1016/j.adengl.2019.03.022"
  "estado" => "S300"
  "fechaPublicacion" => "2019-09-01"
  "aid" => "2201"
  "copyrightAnyo" => "2019"
  "documento" => "simple-article"
  "crossmark" => 1
  "subdocumento" => "cor"
  "cita" => "Actas Dermosifiliogr. 2019;110:520"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:1 [
    "total" => 0
  ]
  "Traduccion" => array:1 [
    "es" => array:19 [
      "pii" => "S0001731019301590"
      "issn" => "00017310"
      "doi" => "10.1016/j.ad.2019.03.009"
      "estado" => "S300"
      "fechaPublicacion" => "2019-09-01"
      "aid" => "2201"
      "copyright" => "AEDV"
      "documento" => "simple-article"
      "crossmark" => 1
      "subdocumento" => "cor"
      "cita" => "Actas Dermosifiliogr. 2019;110:520"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 191
        "formatos" => array:2 [
          "HTML" => 135
          "PDF" => 56
        ]
      ]
      "es" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Comentarios Editoriales</span>"
        "titulo" => "Ixekizumab y psoriasis&#44; &#191;qu&#233; sucede en el mundo real&#63;"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "paginas" => array:1 [
          0 => array:1 [
            "paginaInicial" => "520"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Ixekizumab and Psoriasis in the Real World"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "I&#46; Belinch&#243;n Romero"
            "autores" => array:1 [
              0 => array:2 [
                "nombre" => "I&#46;"
                "apellidos" => "Belinch&#243;n Romero"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S1578219019302070"
          "doi" => "10.1016/j.adengl.2019.03.022"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219019302070?idApp=UINPBA000044"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731019301590?idApp=UINPBA000044"
      "url" => "/00017310/0000011000000007/v1_201909021023/S0001731019301590/v1_201909021023/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S1578219019301957"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2018.08.001"
    "estado" => "S300"
    "fechaPublicacion" => "2019-09-01"
    "aid" => "2087"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and AEDV"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "rev"
    "cita" => "Actas Dermosifiliogr. 2019;110:521-5"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1
      "HTML" => 1
    ]
    "en" => array:12 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Review</span>"
      "titulo" => "Evaluation of Sexual Life and Marital Satisfaction in Patients with Anogenital Wart"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "521"
          "paginaFinal" => "525"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Evaluaci&#243;n de la vida sexual y de la satisfacci&#243;n matrimonial en pacientes con verruga anogenital"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "M&#46; Nahidi, Y&#46; Nahidi, G&#46; Kardan, L&#46; Jarahi, B&#46; Aminzadeh, P&#46; Shojaei, M&#46;R&#46; Fayyazi Bordbar"
          "autores" => array:7 [
            0 => array:2 [
              "nombre" => "M&#46;"
              "apellidos" => "Nahidi"
            ]
            1 => array:2 [
              "nombre" => "Y&#46;"
              "apellidos" => "Nahidi"
            ]
            2 => array:2 [
              "nombre" => "G&#46;"
              "apellidos" => "Kardan"
            ]
            3 => array:2 [
              "nombre" => "L&#46;"
              "apellidos" => "Jarahi"
            ]
            4 => array:2 [
              "nombre" => "B&#46;"
              "apellidos" => "Aminzadeh"
            ]
            5 => array:2 [
              "nombre" => "P&#46;"
              "apellidos" => "Shojaei"
            ]
            6 => array:2 [
              "nombre" => "M&#46;R&#46; Fayyazi"
              "apellidos" => "Bordbar"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0001731018304848"
        "doi" => "10.1016/j.ad.2018.08.005"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731018304848?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219019301957?idApp=UINPBA000044"
    "url" => "/15782190/0000011000000007/v1_201909021030/S1578219019301957/v1_201909021030/en/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S1578219019302094"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2019.05.014"
    "estado" => "S300"
    "fechaPublicacion" => "2019-09-01"
    "aid" => "2228"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and AEDV"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "cor"
    "cita" => "Actas Dermosifiliogr. 2019;110:518-9"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1
      "HTML" => 1
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Comentarios Editoriales</span>"
      "titulo" => "Patient-Reported Outcomes in Psoriasis Validated in Spain&#58; PROs and Cons"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "518"
          "paginaFinal" => "519"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Patient reported outcomes en psoriasis validados en Espa&#241;a&#58; PROs y contras"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "L&#46; Puig"
          "autores" => array:1 [
            0 => array:2 [
              "nombre" => "L&#46;"
              "apellidos" => "Puig"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0001731019301930"
        "doi" => "10.1016/j.ad.2019.05.001"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731019301930?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219019302094?idApp=UINPBA000044"
    "url" => "/15782190/0000011000000007/v1_201909021030/S1578219019302094/v1_201909021030/en/main.assets"
  ]
  "en" => array:14 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Commentaries</span>"
    "titulo" => "Ixekizumab and Psoriasis in the Real World"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:1 [
        "paginaInicial" => "520"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "I&#46; Belinch&#243;n Romero"
        "autores" => array:1 [
          0 => array:3 [
            "nombre" => "I&#46;"
            "apellidos" => "Belinch&#243;n Romero"
            "email" => array:1 [
              0 => "belinchon_isa@gva.es"
            ]
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Servicio de Dermatolog&#237;a&#44; Hospital General Universitario de Alicante-ISABIAL&#44; Universidad Miguel Hern&#225;ndez&#44; Alicante&#44; Spain"
            "identificador" => "aff0005"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Ixekizumab and Psoriasis in the Real WorldIxekizumab y psoriasis&#44; &#191;qu&#233; sucede en el mundo real&#63;"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Psoriasis is an autoimmune disease with a complex pathogenesis in which the interaction of immunologic&#44; genetic&#44; and environmental factors results in different clinical forms&#44; as well as different response to treatments&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">In recent years&#44; better understanding of the disease pathogenesis has enabled development of agents with new therapeutic targets&#44; with excellent results in clinical trials&#44; particularly in the case of moderate to severe forms of the disease&#46; However&#44; study of the treatment of psoriasis in clinical practice is necessary&#44; as the patients included in clinical trials are not fully representative of those treated in this setting&#46;<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">1</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">Ixekizumab is a humanized recombinant biologic agent that targets IL-17A and that was recently approved for the treatment of moderate to severe plaque psoriasis&#46; The efficacy and safety of the agent has been assessed in randomized clinical trials&#44; although there is limited data on its use in routine clinical practice&#46;<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">2</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">In this issue&#44; Magdaleno-Tapial et al&#46;<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">3</span></a> describe their study of the efficacy and safety of ixekizumab in patients with psoriasis in routine clinical practice in 2 hospitals in the Mediterranean region&#46; This retrospective&#44; observational study included 75 patients with moderate to severe psoriasis&#44; some of whom had psoriasis in difficult-to-treat locations&#44; and who received ixekizumab for a mean duration of 46 weeks&#46; The authors demonstrated the efficacy and safety of the agent in routine clinical practice and&#44; although this is not the first study in the clinical setting&#44;<a class="elsevierStyleCrossRefs" href="#bib0045"><span class="elsevierStyleSup">4&#44;5</span></a> it is the second largest series to date&#44; and confirms the efficacy findings of previous studies&#46; In addition&#44; this study describes the efficacy of ixekizumab in difficult-to-treat sites such as the scalp&#44; genital area&#44; or palmoplantar region&#46; The safety data are similar to those reported both in clinical trials and in studies in a clinical setting&#46;</p><p id="par0025" class="elsevierStylePara elsevierViewall">In summary&#44; this study provides valuable information on the treatment with ixekizumab of patients with psoriasis vulgaris and psoriasis in difficult-to-treat sites in a clinical practice setting&#46; Nevertheless&#44; larger studies and registries of routine clinical practice will be needed to extend our knowledge in a real-world setting&#46;</p></span>"
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2019-03-18"
    "fechaAceptado" => "2019-03-19"
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as&#58; Belinch&#243;n Romero I&#46; Ixekizumab and Psoriasis in the Real World&#46; Actas Dermosifiliogr&#46; 2019&#59;110&#58;521&#46;</p>"
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:5 [
            0 => array:3 [
              "identificador" => "bib0030"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Risk of serious adverse events associated with biologic and nonbiologic psoriasis systemic therapy&#58; Patients ineligible vs eligible for randomized controlled trials"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "I&#46; Garcia-Doval"
                            1 => "G&#46; Carretero"
                            2 => "F&#46; Vanaclocha"
                            3 => "C&#46; Ferrandiz"
                            4 => "E&#46; Daud&#233;n"
                            5 => "J&#46;L&#46; S&#225;nchez-Carazo"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/archdermatol.2011.2768"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Dermatol"
                        "fecha" => "2012"
                        "volumen" => "148"
                        "paginaInicial" => "463"
                        "paginaFinal" => "470"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22508869"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and safety of ixekizumab for the treatment of moderate-to-severe plaque psoriasis&#58; Results through 108&#160;weeks of a randomized&#44; controlled phase 3 clinical trial &#40;UNCOVER-3&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46; Blauvelt"
                            1 => "M&#46; Gooderham"
                            2 => "L&#46; Iversen"
                            3 => "S&#46; Ball"
                            4 => "L&#46; Zhang"
                            5 => "N&#46;O&#46; Agada"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jaad.2017.06.153"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Acad Dermatol"
                        "fecha" => "2017"
                        "volumen" => "77"
                        "paginaInicial" => "855"
                        "paginaFinal" => "862"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28917383"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Eficacia y seguridad de ixekizumab en la pr&#225;ctica cl&#237;nica habitual&#58; estudio retrospectivo bic&#233;ntrico"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; Magdaleno-Tapial"
                            1 => "R&#46; Carmena-Ram&#243;n"
                            2 => "C&#46; Valenzuela-O&#241;ate"
                            3 => "J&#46;M&#46; Ortiz-Salvador"
                            4 => "J&#46; Sabater-Abad"
                            5 => "P&#46; Hern&#225;ndez-Bel"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:2 [
                        "tituloSerie" => "Actas Dermosifiliogr"
                        "fecha" => "2019"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0045"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Ixekizumab for treatment of moderate to severe plaque psoriasis&#58; Real world clinical experience"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "F&#46; Diotallevi"
                            1 => "A&#46; Campanati"
                            2 => "G&#46; Radi"
                            3 => "E&#46; Molinelli"
                            4 => "A&#46; Offidani"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.23736/S0392-0488.18.06094-7"
                      "Revista" => array:2 [
                        "tituloSerie" => "G Ital Dermatol Venereol"
                        "fecha" => "2018"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0050"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Initial results of ixekizumab efficacy and safety in real-world plaque psoriasis patients&#58; A multicentre retrospective study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "G&#46; Deza"
                            1 => "J&#46; Notario"
                            2 => "A&#46; Lopez-Ferrer"
                            3 => "E&#46; Vilarrasa"
                            4 => "M&#46; Ferran"
                            5 => "E&#46; del Alcazar"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/jdv.15288"
                      "Revista" => array:5 [
                        "tituloSerie" => "J Eur Acad Dermatol Venereol"
                        "fecha" => "2019"
                        "volumen" => "33"
                        "paginaInicial" => "553"
                        "paginaFinal" => "5598"
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/15782190/0000011000000007/v1_201909021030/S1578219019302070/v1_201909021030/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "66476"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Commentaries"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/15782190/0000011000000007/v1_201909021030/S1578219019302070/v1_201909021030/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219019302070?idApp=UINPBA000044"
]
Share
Journal Information

Statistics

Follow this link to access the full text of the article

Commentaries
Ixekizumab and Psoriasis in the Real World
Ixekizumab and Psoriasis in the Real WorldIxekizumab y psoriasis, ¿qué sucede en el mundo real?
I. Belinchón Romero
Servicio de Dermatología, Hospital General Universitario de Alicante-ISABIAL, Universidad Miguel Hernández, Alicante, Spain
Read
3677
Times
was read the article
1547
Total PDF
2130
Total HTML
Share statistics
 array:23 [
  "pii" => "S1578219019302070"
  "issn" => "15782190"
  "doi" => "10.1016/j.adengl.2019.03.022"
  "estado" => "S300"
  "fechaPublicacion" => "2019-09-01"
  "aid" => "2201"
  "copyrightAnyo" => "2019"
  "documento" => "simple-article"
  "crossmark" => 1
  "subdocumento" => "cor"
  "cita" => "Actas Dermosifiliogr. 2019;110:520"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:1 [
    "total" => 0
  ]
  "Traduccion" => array:1 [
    "es" => array:19 [
      "pii" => "S0001731019301590"
      "issn" => "00017310"
      "doi" => "10.1016/j.ad.2019.03.009"
      "estado" => "S300"
      "fechaPublicacion" => "2019-09-01"
      "aid" => "2201"
      "copyright" => "AEDV"
      "documento" => "simple-article"
      "crossmark" => 1
      "subdocumento" => "cor"
      "cita" => "Actas Dermosifiliogr. 2019;110:520"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 191
        "formatos" => array:2 [
          "HTML" => 135
          "PDF" => 56
        ]
      ]
      "es" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Comentarios Editoriales</span>"
        "titulo" => "Ixekizumab y psoriasis&#44; &#191;qu&#233; sucede en el mundo real&#63;"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "paginas" => array:1 [
          0 => array:1 [
            "paginaInicial" => "520"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Ixekizumab and Psoriasis in the Real World"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "I&#46; Belinch&#243;n Romero"
            "autores" => array:1 [
              0 => array:2 [
                "nombre" => "I&#46;"
                "apellidos" => "Belinch&#243;n Romero"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S1578219019302070"
          "doi" => "10.1016/j.adengl.2019.03.022"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219019302070?idApp=UINPBA000044"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731019301590?idApp=UINPBA000044"
      "url" => "/00017310/0000011000000007/v1_201909021023/S0001731019301590/v1_201909021023/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S1578219019301957"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2018.08.001"
    "estado" => "S300"
    "fechaPublicacion" => "2019-09-01"
    "aid" => "2087"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and AEDV"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "rev"
    "cita" => "Actas Dermosifiliogr. 2019;110:521-5"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1
      "HTML" => 1
    ]
    "en" => array:12 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Review</span>"
      "titulo" => "Evaluation of Sexual Life and Marital Satisfaction in Patients with Anogenital Wart"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "521"
          "paginaFinal" => "525"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Evaluaci&#243;n de la vida sexual y de la satisfacci&#243;n matrimonial en pacientes con verruga anogenital"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "M&#46; Nahidi, Y&#46; Nahidi, G&#46; Kardan, L&#46; Jarahi, B&#46; Aminzadeh, P&#46; Shojaei, M&#46;R&#46; Fayyazi Bordbar"
          "autores" => array:7 [
            0 => array:2 [
              "nombre" => "M&#46;"
              "apellidos" => "Nahidi"
            ]
            1 => array:2 [
              "nombre" => "Y&#46;"
              "apellidos" => "Nahidi"
            ]
            2 => array:2 [
              "nombre" => "G&#46;"
              "apellidos" => "Kardan"
            ]
            3 => array:2 [
              "nombre" => "L&#46;"
              "apellidos" => "Jarahi"
            ]
            4 => array:2 [
              "nombre" => "B&#46;"
              "apellidos" => "Aminzadeh"
            ]
            5 => array:2 [
              "nombre" => "P&#46;"
              "apellidos" => "Shojaei"
            ]
            6 => array:2 [
              "nombre" => "M&#46;R&#46; Fayyazi"
              "apellidos" => "Bordbar"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0001731018304848"
        "doi" => "10.1016/j.ad.2018.08.005"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731018304848?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219019301957?idApp=UINPBA000044"
    "url" => "/15782190/0000011000000007/v1_201909021030/S1578219019301957/v1_201909021030/en/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S1578219019302094"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2019.05.014"
    "estado" => "S300"
    "fechaPublicacion" => "2019-09-01"
    "aid" => "2228"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and AEDV"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "cor"
    "cita" => "Actas Dermosifiliogr. 2019;110:518-9"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1
      "HTML" => 1
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Comentarios Editoriales</span>"
      "titulo" => "Patient-Reported Outcomes in Psoriasis Validated in Spain&#58; PROs and Cons"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "518"
          "paginaFinal" => "519"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Patient reported outcomes en psoriasis validados en Espa&#241;a&#58; PROs y contras"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "L&#46; Puig"
          "autores" => array:1 [
            0 => array:2 [
              "nombre" => "L&#46;"
              "apellidos" => "Puig"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0001731019301930"
        "doi" => "10.1016/j.ad.2019.05.001"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731019301930?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219019302094?idApp=UINPBA000044"
    "url" => "/15782190/0000011000000007/v1_201909021030/S1578219019302094/v1_201909021030/en/main.assets"
  ]
  "en" => array:14 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Commentaries</span>"
    "titulo" => "Ixekizumab and Psoriasis in the Real World"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:1 [
        "paginaInicial" => "520"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "I&#46; Belinch&#243;n Romero"
        "autores" => array:1 [
          0 => array:3 [
            "nombre" => "I&#46;"
            "apellidos" => "Belinch&#243;n Romero"
            "email" => array:1 [
              0 => "belinchon_isa@gva.es"
            ]
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Servicio de Dermatolog&#237;a&#44; Hospital General Universitario de Alicante-ISABIAL&#44; Universidad Miguel Hern&#225;ndez&#44; Alicante&#44; Spain"
            "identificador" => "aff0005"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Ixekizumab and Psoriasis in the Real WorldIxekizumab y psoriasis&#44; &#191;qu&#233; sucede en el mundo real&#63;"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Psoriasis is an autoimmune disease with a complex pathogenesis in which the interaction of immunologic&#44; genetic&#44; and environmental factors results in different clinical forms&#44; as well as different response to treatments&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">In recent years&#44; better understanding of the disease pathogenesis has enabled development of agents with new therapeutic targets&#44; with excellent results in clinical trials&#44; particularly in the case of moderate to severe forms of the disease&#46; However&#44; study of the treatment of psoriasis in clinical practice is necessary&#44; as the patients included in clinical trials are not fully representative of those treated in this setting&#46;<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">1</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">Ixekizumab is a humanized recombinant biologic agent that targets IL-17A and that was recently approved for the treatment of moderate to severe plaque psoriasis&#46; The efficacy and safety of the agent has been assessed in randomized clinical trials&#44; although there is limited data on its use in routine clinical practice&#46;<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">2</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">In this issue&#44; Magdaleno-Tapial et al&#46;<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">3</span></a> describe their study of the efficacy and safety of ixekizumab in patients with psoriasis in routine clinical practice in 2 hospitals in the Mediterranean region&#46; This retrospective&#44; observational study included 75 patients with moderate to severe psoriasis&#44; some of whom had psoriasis in difficult-to-treat locations&#44; and who received ixekizumab for a mean duration of 46 weeks&#46; The authors demonstrated the efficacy and safety of the agent in routine clinical practice and&#44; although this is not the first study in the clinical setting&#44;<a class="elsevierStyleCrossRefs" href="#bib0045"><span class="elsevierStyleSup">4&#44;5</span></a> it is the second largest series to date&#44; and confirms the efficacy findings of previous studies&#46; In addition&#44; this study describes the efficacy of ixekizumab in difficult-to-treat sites such as the scalp&#44; genital area&#44; or palmoplantar region&#46; The safety data are similar to those reported both in clinical trials and in studies in a clinical setting&#46;</p><p id="par0025" class="elsevierStylePara elsevierViewall">In summary&#44; this study provides valuable information on the treatment with ixekizumab of patients with psoriasis vulgaris and psoriasis in difficult-to-treat sites in a clinical practice setting&#46; Nevertheless&#44; larger studies and registries of routine clinical practice will be needed to extend our knowledge in a real-world setting&#46;</p></span>"
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2019-03-18"
    "fechaAceptado" => "2019-03-19"
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as&#58; Belinch&#243;n Romero I&#46; Ixekizumab and Psoriasis in the Real World&#46; Actas Dermosifiliogr&#46; 2019&#59;110&#58;521&#46;</p>"
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:5 [
            0 => array:3 [
              "identificador" => "bib0030"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Risk of serious adverse events associated with biologic and nonbiologic psoriasis systemic therapy&#58; Patients ineligible vs eligible for randomized controlled trials"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "I&#46; Garcia-Doval"
                            1 => "G&#46; Carretero"
                            2 => "F&#46; Vanaclocha"
                            3 => "C&#46; Ferrandiz"
                            4 => "E&#46; Daud&#233;n"
                            5 => "J&#46;L&#46; S&#225;nchez-Carazo"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/archdermatol.2011.2768"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Dermatol"
                        "fecha" => "2012"
                        "volumen" => "148"
                        "paginaInicial" => "463"
                        "paginaFinal" => "470"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22508869"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and safety of ixekizumab for the treatment of moderate-to-severe plaque psoriasis&#58; Results through 108&#160;weeks of a randomized&#44; controlled phase 3 clinical trial &#40;UNCOVER-3&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46; Blauvelt"
                            1 => "M&#46; Gooderham"
                            2 => "L&#46; Iversen"
                            3 => "S&#46; Ball"
                            4 => "L&#46; Zhang"
                            5 => "N&#46;O&#46; Agada"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jaad.2017.06.153"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Acad Dermatol"
                        "fecha" => "2017"
                        "volumen" => "77"
                        "paginaInicial" => "855"
                        "paginaFinal" => "862"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28917383"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Eficacia y seguridad de ixekizumab en la pr&#225;ctica cl&#237;nica habitual&#58; estudio retrospectivo bic&#233;ntrico"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; Magdaleno-Tapial"
                            1 => "R&#46; Carmena-Ram&#243;n"
                            2 => "C&#46; Valenzuela-O&#241;ate"
                            3 => "J&#46;M&#46; Ortiz-Salvador"
                            4 => "J&#46; Sabater-Abad"
                            5 => "P&#46; Hern&#225;ndez-Bel"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:2 [
                        "tituloSerie" => "Actas Dermosifiliogr"
                        "fecha" => "2019"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0045"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Ixekizumab for treatment of moderate to severe plaque psoriasis&#58; Real world clinical experience"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "F&#46; Diotallevi"
                            1 => "A&#46; Campanati"
                            2 => "G&#46; Radi"
                            3 => "E&#46; Molinelli"
                            4 => "A&#46; Offidani"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.23736/S0392-0488.18.06094-7"
                      "Revista" => array:2 [
                        "tituloSerie" => "G Ital Dermatol Venereol"
                        "fecha" => "2018"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0050"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Initial results of ixekizumab efficacy and safety in real-world plaque psoriasis patients&#58; A multicentre retrospective study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "G&#46; Deza"
                            1 => "J&#46; Notario"
                            2 => "A&#46; Lopez-Ferrer"
                            3 => "E&#46; Vilarrasa"
                            4 => "M&#46; Ferran"
                            5 => "E&#46; del Alcazar"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/jdv.15288"
                      "Revista" => array:5 [
                        "tituloSerie" => "J Eur Acad Dermatol Venereol"
                        "fecha" => "2019"
                        "volumen" => "33"
                        "paginaInicial" => "553"
                        "paginaFinal" => "5598"
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/15782190/0000011000000007/v1_201909021030/S1578219019302070/v1_201909021030/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "66476"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Commentaries"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/15782190/0000011000000007/v1_201909021030/S1578219019302070/v1_201909021030/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219019302070?idApp=UINPBA000044"
]
Article information
ISSN: 15782190
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 7 4 11
2024 October 68 31 99
2024 September 68 24 92
2024 August 88 49 137
2024 July 72 38 110
2024 June 69 28 97
2024 May 67 31 98
2024 April 55 24 79
2024 March 56 26 82
2024 February 43 33 76
2024 January 39 32 71
2023 December 38 20 58
2023 November 51 33 84
2023 October 46 22 68
2023 September 36 30 66
2023 August 21 12 33
2023 July 50 35 85
2023 June 34 20 54
2023 May 31 24 55
2023 April 28 13 41
2023 March 31 19 50
2023 February 27 22 49
2023 January 25 24 49
2022 December 38 46 84
2022 November 26 32 58
2022 October 22 18 40
2022 September 15 49 64
2022 August 19 33 52
2022 July 18 39 57
2022 June 17 32 49
2022 May 30 32 62
2022 April 30 43 73
2022 March 39 45 84
2022 February 29 24 53
2022 January 30 36 66
2021 December 29 35 64
2021 November 26 42 68
2021 October 35 48 83
2021 September 26 36 62
2021 August 24 24 48
2021 July 33 19 52
2021 June 30 19 49
2021 May 36 37 73
2021 April 77 29 106
2021 March 47 20 67
2021 February 64 30 94
2021 January 49 19 68
2020 December 34 17 51
2020 November 29 20 49
2020 October 28 7 35
2020 September 31 10 41
2020 August 34 13 47
2020 July 22 14 36
2020 June 32 37 69
2020 May 28 10 38
2020 April 21 15 36
2020 March 26 17 43
2020 February 6 6 12
Show all

Follow this link to access the full text of the article

Idiomas
Actas Dermo-Sifiliográficas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?